Rifatiroin

Roman name

Rifathyroinum

Of drugs

Rifatiroin is one of the main rilizingfactorov hypothalamus (/ liberinov / neirogormonov incentives for specific pituitary hormones). He helped to release tireotroponogo pituitary hormone (pituitary hormone to regulate the thyroid gland), ie rilizingfactorom tireotroponogo hormone. At the same time rifatiroin has multiple effects on the body. It stimulates the secretion of prolactin (a pituitary hormone, which encourages the molokootdelenia), the anti-activity (removes the frustration).

Storage conditions

List B. In the dark place at a temperature of 4 ° C.

Indications for use

The application rifatiroin is as a means of diagnosis of various forms of hypothyroidism (lowered the thyroid gland), as well as the гипоталамогнпофизарн отиреоидной system (functional complex organism, which is a regulation of the thyroid hormone hypothalamus by influencing the FIG) in a variety of endocrine diseases; it is also employed to determine gipofizarnogo reserve prolactin (Stock gipofize hormone, enabling processes molokootdelenia) in women with the hypothetical and agalactiei (decrease or absence of milk), and endocrine disruption.

Dosing and Administration

Misleading users struino single dose of 500 micrograms (0.5 mg). Prior to the introduction and 15; 30 and 120 min after the introduction of the contents of tireotroponogo hormone and prolactin in the blood.

Side-Effects

Since the introduction rifatiroina in 1-2 min possible nausea, feeling heat, dizziness, passing themselves.

Contraindications

The rifatiroina contraindicated in pregnancy.

Form of

In sealed ampoules containing 500 µ g of dry product. Before use, manage 500 g in 2 ml of sterile water for injection or izotoniceski solution of sodium chloride.

Directory → Hormones and their antagonists → Hormones hypothalamus, pituitary, gonadotropin and their antagonists → Rifatiroin